Interestingly, in an in vitro kinase assay with purified GSK3α and tau, the addition of Aβ42 peptides stimulated GSK3α-dependent phosphorylation of tau at Ser396, indicating that GSK3α is a link between the two pathological hallmarks found in the tissue of AD patients [33]. Here, GSK3A is linked to Alzheimer disease.